Study of Mind-Body Skills Groups for Adolescents With Depression in Primary Care

March 9, 2020 updated by: Michelle Salyers, Indiana University

Pilot Study of Mind-Body Skills Groups for Adolescents With Depression in Primary Care

The Center for Mind -Body Medicine has developed a mind-body skills group program that incorporates meditation, guided imagery, breathing techniques, autogenic training, biofeedback, genograms, and self-expression through words, drawings, and movement. These mind-body skills are designed to increase self-awareness and self-regulation. This program has been shown to significantly improve depression symptoms in children and adolescents with posttraumatic stress disorder in Gaza, but it has not yet been tested in a US adolescent population. The purpose of this study is to determine the feasibility of using mind-body skills groups to reduce depression in adolescents and to investigate the effects of the program on factors such as self-efficacy, mindfulness and rumination which are likely to mediate improvement.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

49

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Indiana
      • Indianapolis, Indiana, United States, 46254
        • Eskenazi Health Primary Care

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

13 years to 17 years (CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Eskenazi Primary Care patients at time of screening
  • 13-17 years old
  • Diagnosis of depression confirmed by Mini International Neuropsychiatric Interview (MINI) Kid Screen (with adolescent)
  • English speaking
  • Willingness to attend mind body skills group for duration of the intervention (10 sessions over approximately 10 weeks)

Exclusion Criteria:

  • History of bipolar disorder or psychosis
  • Acute and immediate risk of suicide, determined by clinical assessment
  • Lack of capacity to assent (adolescent) or lack of capacity to consent (parent/guardian)
  • Previous participation by the adolescent in the Eskenazi Mind Body Group intervention

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: mind-body-skills intervention
mind-body-skills group intervention offered weekly for 10 weeks
mind-body skills group program incorporates meditation, guided imagery, breathing techniques, autogenic training, biofeedback, genograms, and self-expression through words, drawings, and movement

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Children's Depression Inventory-2 (CDI-2) scores
Time Frame: from baseline to within one month after end of intervention
self report long version (28 items) to assess the presence and severity of depressive symptoms in children
from baseline to within one month after end of intervention
Change in Children's Depression Inventory-2 (CDI-2) scores
Time Frame: from baseline to approximately 3 months after end of intervention
self report long version (28 items) to assess the presence and severity of depressive symptoms in children
from baseline to approximately 3 months after end of intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Patient Health Questionnaire-9 (PHQ-9) score
Time Frame: from baseline to within one month after end of intervention
self report (9 questions) to screen for the presence and severity of depression
from baseline to within one month after end of intervention
Change in Patient Health Questionnaire-9 (PHQ-9) score
Time Frame: from baseline to approximately 3 months after end of intervention
self report (9 questions) to screen for the presence and severity of depression
from baseline to approximately 3 months after end of intervention
Change in Rumination Subscale of the Children's Response Style Questionnaire Score
Time Frame: from baseline to within one month after end of intervention
self report (13 questions) of rumination symptoms
from baseline to within one month after end of intervention
Change in Rumination Subscale of the Children's Response Style Questionnaire Score
Time Frame: from baseline to approximately 3 months after end of intervention
self report (13 questions) of rumination symptoms
from baseline to approximately 3 months after end of intervention
Change in Mindful Attention Awareness Scale-Adolescent (MAAS) score
Time Frame: from baseline to within one month after end of intervention
self report (14 questions) designed to assess open or receptive awareness of and attention to what is taking place in the present
from baseline to within one month after end of intervention
Change in Mindful Attention Awareness Scale-Adolescent (MAAS) score
Time Frame: from baseline to approximately 3 months after end of intervention
self report (14 questions) designed to assess open or receptive awareness of and attention to what is taking place in the present
from baseline to approximately 3 months after end of intervention
Change in Self-Efficacy Questionnaire for Depression in Adolescents (SEQ-DA) score
Time Frame: from baseline to within one month after end of intervention
self report (12 items) designed to measure self-perceived ability to cope with depressive symptoms
from baseline to within one month after end of intervention
Change in Self-Efficacy Questionnaire for Depression in Adolescents (SEQ-DA) score
Time Frame: from baseline to approximately 3 months after end of intervention
self report (12 items) designed to measure self-perceived ability to cope with depressive symptoms
from baseline to approximately 3 months after end of intervention
Change in Suicide Ideation Questionnaire (SIQ) score
Time Frame: from baseline to within one month after end of intervention
self report (30 or 15 items depending on grade level) to assess frequency of suicidal ideation
from baseline to within one month after end of intervention
Change in Suicide Ideation Questionnaire (SIQ) score
Time Frame: from baseline to approximately 3 months after end of intervention
self report (30 or 15 items depending on grade level) to assess frequency of suicidal ideation
from baseline to approximately 3 months after end of intervention
Acceptability Questionnaire
Time Frame: within one month after end of intervention
self report (15 items) intervention acceptability assessment of usefulness and helpfulness of the intervention
within one month after end of intervention
Acceptability Questionnaire
Time Frame: approximately 3 months after end of intervention
self report (15 items) intervention acceptability assessment of usefulness and helpfulness of the intervention
approximately 3 months after end of intervention
Acceptability Questionnaire - open-ended questions for qualitative analyses
Time Frame: within one month after end of intervention
3 open-ended questions to gather qualitative data about the usefulness and helpfulness of the intervention
within one month after end of intervention
Acceptability Questionnaire - open-ended questions for qualitative analyses
Time Frame: approximately 3 months after end of intervention
3 open-ended questions to gather qualitative data about the usefulness and helpfulness of the intervention
approximately 3 months after end of intervention
Change in Hope Scale Score
Time Frame: from baseline to within one month after end of intervention
  • self report (12 items), 4-point Likert scale(1=Definitely False to 4=Definitely True)
  • evaluates global hope (range 8-32); there are also 2 subscales: hope agency (range 4-16) and hope pathways (range 4-16)
  • includes distracter items
  • global hope score calculated by summing the hope agency and hope pathways scores (omitting distracter items)
  • higher scores indicate a person has higher hope
from baseline to within one month after end of intervention
Change in Hope Scale Score
Time Frame: from baseline to approximately 3 months after end of intervention
  • self report (12 items), 4-point Likert scale(1=Definitely False to 4=Definitely True)
  • evaluates global hope (range 8-32); there are also 2 subscales: hope agency (range 4-16) and hope pathways (range 4-16)
  • includes distracter items
  • global hope score calculated by summing the hope agency and hope pathways scores (omitting distracter items)
  • higher scores indicate a person has higher hope
from baseline to approximately 3 months after end of intervention
Change in Warwick-Edinburgh Mental Well-Being Scale (WEMWBS) Score
Time Frame: from baseline to within one month after end of intervention
  • self report (14 items) to measure positive affect, satisfying interpersonal relationships, and positive functioning
  • 5-point Likert scale (1=none of the time to 5=all of the time)
  • total score is calculated by summing each item score (range 14-70)
  • higher scores represent increased levels of mental wellbeing
from baseline to within one month after end of intervention
Change in Warwick-Edinburgh Mental Well-Being Scale (WEMWBS) Score
Time Frame: from baseline to approximately 3 months after end of intervention
  • self report (14 items) to measure positive affect, satisfying interpersonal relationships, and positive functioning (range 14-70)
  • 5-point Likert scale (1=none of the time to 5=all of the time)
  • total score is calculated by summing each item score (range 14-70)
  • higher scores represent increased levels of mental wellbeing
from baseline to approximately 3 months after end of intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Michelle P Salyers, PhD, Indiana University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 25, 2018

Primary Completion (ACTUAL)

September 4, 2019

Study Completion (ACTUAL)

September 4, 2019

Study Registration Dates

First Submitted

November 21, 2017

First Submitted That Met QC Criteria

December 4, 2017

First Posted (ACTUAL)

December 6, 2017

Study Record Updates

Last Update Posted (ACTUAL)

March 10, 2020

Last Update Submitted That Met QC Criteria

March 9, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depressive Disorder

Clinical Trials on mind-body-skills group

Subscribe